Clinical Trials Logo

Clinical Trial Summary

In this study, we planned to investigate the role and determine the predictive performance of both APACHE II and SAPS II scoring systems and compare them in COVID-19 patients admitted to the intensive care unit of Assiut University Hospital.


Clinical Trial Description

Since the start of the coronavirus disease 2019 (COVID-19) pandemic, intensive care units (ICUs) worldwide have struggled to treat affected patients who require a completely different approach to treatment than other patients - [1]* .This study aims to evaluate the efficacy of single dose analgesia in combination with local anaesthesia to control pain during TUS guided procedures. It also aims to assess the effect of its use on procedure performance time and rate of complications occurrence compared to local anaesthesia alone.Although many severe cases are admitted to ICUs, it is unknown whether the conventional disease-severity scoring systems that were developed for ICU patients can be applied to patients with COVID-19.Several recent studies have used Acute Physiology and Chronic Health Evaluation (APACHE) and Simplified Acute Physiology Score (SAPS) to provide information on the clinical severity of COVID-19 - [2-4]*. However, very few reports have examined their validity of applying them to patients with COVID-19. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05308524
Study type Observational
Source Assiut University
Contact Ebtesam Mohamed thabet, 1
Phone 01020135853
Email ebtesamm582@gmail.com
Status Not yet recruiting
Phase
Start date April 1, 2022
Completion date December 2023